Nick Gent Selected Research

5- (3- hydroxymethyl- 3- methyl- 1- triazeno)imidazole- 4- carboxamide (HMIC)

4/2022

Respiratory syncytial virus-associated hospitalisation in children aged ≤5 years: a scoping review of literature from 2009 to 2021.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nick Gent Research Topics

Disease

3	Infections 12/2022 - 09/2016
2	COVID-19 12/2022 - 12/2021
1	Bronchiolitis 04/2022
1	Breakthrough Infections 12/2021
1	Ebola Hemorrhagic Fever 12/2018
1	Communicable Diseases (Infectious Diseases) 12/2018
1	Gastroenteritis 09/2016
1	Poisoning 09/2016
1	Disease Progression 09/2016

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 12/2022 - 12/2021
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022
1	5- (3- hydroxymethyl- 3- methyl- 1- triazeno)imidazole- 4- carboxamide (HMIC)IBA 04/2022
1	EpitopesIBA 12/2021
1	Monoclonal AntibodiesIBA 01/2021
1	ThalliumIBA 09/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2016
1	Polonium-210IBA 09/2016

Therapy/Procedure

1	Personal Protective Equipment 12/2018